UBS upgrades Thermo Fisher Scientific stock as growth outlook improves
Published on 10/07/2026 at 16:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific stock (ISIN US8835561023) was EUR 585.10 at Lang & Schwarz on October 7, 2026 at 4:03 p.m. CEST, up 0.46 percent versus the prior close of EUR 582.40. On October 6, Investing.com reported that UBS upgraded the stock from Neutral to Buy and linked the change to a stronger growth outlook.
UBS sees growth returning
The UBS view points to projected organic revenue growth of 5.00-6.00 percent by 2027, while the same report highlighted the prospect of operating-margin expansion and double-digit earnings-per-share growth. That outlook gives the upgrade a specific operating basis rather than relying only on valuation momentum.
The valuation signal is more restrained. MarketBeat reported a consensus target of USD 628.78, below the USD 694.33 52-week high cited in its October 6 article. Deutsche Bank had reiterated a Buy rating and a USD 720.00 target on September 25, according to the same MarketBeat report.
Second-quarter figures reset the baseline
Yahoo Finance published the second-quarter 2026 earnings call transcript dated July 23, 2026. Management reported revenue of USD 11.99 billion, up 10.00 percent year over year, adjusted earnings per share of USD 6.03, up 13.00 percent, and adjusted operating income of USD 2.73 billion, up 15.00 percent.
Adjusted operating margin reached 22.80 percent in the second quarter, 0.90 percentage points above the prior-year quarter. The company raised full-year 2026 guidance to USD 47.40 billion-USD 48.10 billion of revenue and USD 24.93-USD 25.33 of adjusted earnings per share, with the midpoint of the earnings range USD 0.25 higher than the previous outlook.
Stock remains below the yearly high
The primary listing is on the NYSE in USD, while the German reference price remains the Lang & Schwarz euro quote. Finance data put Thermo Fisher Scientific's market capitalization at USD 241.5 billion and its 52-week range at USD 435.27 to USD 694.33 as of October 7, 2026. The euro quote therefore sits below the latest US-dollar high, and the small daily gain leaves the next earnings date as the more immediate scheduled test for the outlook.
At Lang & Schwarz, Thermo Fisher Scientific stock was trading at EUR 585.10 on October 7, 2026 at 4:03 p.m. CEST, plus 0.46 percent versus the prior close of EUR 582.40 on October 6, 2026. The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- WKN: 857209
- Ticker: TMO
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 7, 2026, 4:03 p.m. CEST: EUR 585.10
- Change versus prior close: plus 0.46 percent
- Prior close Lang & Schwarz October 6, 2026: EUR 582.40
- Market capitalization: USD 241.5 billion as of October 7, 2026
- 52-week range: USD 435.27-USD 694.33 as of October 7, 2026
- Sector / Industry: Healthcare / Medical Diagnostics and Research
